CIK cell
- Generic Name
- CIK cell
CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction
Not Applicable
Not yet recruiting
- Conditions
- Acute Lymphoblastic Leukemia, in RelapseRefractory Acute Lymphoid LeukemiaB-cell Acute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2024-04-30
- Lead Sponsor
- Beijing GoBroad Hospital
- Target Recruit Count
- 213
- Registration Number
- NCT06389305
- Locations
- 🇨🇳
Beijing GoBroad Hospital, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath